Viewing Study NCT06916767

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2025-12-25 @ 10:46 PM
Study NCT ID: NCT06916767
Status: RECRUITING
Last Update Posted: 2025-11-10
First Post: 2025-04-01
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
Sponsor: Paolo Caimi, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed CLL View
None Refractory CLL View
None Refractory Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BAFF CAR-T cells View